Lethaby A, Hickey M
Department of Obstetrics and Gynaecology, University of Auckland, 2nd Floor, National Women's Hospital, Claude Road, Epsom, Auckland, New Zealand.
Cochrane Database Syst Rev. 2002(2):CD001501. doi: 10.1002/14651858.CD001501.
Heavy menstrual bleeding (HMB) is a significant health problem in premenopausal women that can reduce quality of life and cause anaemia. First line therapy has traditionally been medical therapy but this is not always completely effective. Hysterectomy, often used after the failure of medical therapy, is 100% effective but is risky, costly and can cause complications. Endometrial ablation is less invasive, less costly and preserves the uterus. A large number of techniques have been developed to "ablate" (remove) the lining of the endometrium. The gold standard techniques (laser, transcervical resection of the endometrium and rollerball) require visualisation of the uterus with a hysteroscope and, although safe, require skilled surgeons. A number of newer techniques have recently been developed, most of which can be performed blind and are less time consuming. Many of these techniques are still under development, refinement and investigation.
To compare the efficacy, safety and acceptability of methods used to destroy the endometrium to reduce HMB in premenopausal women.
We searched the Cochrane Controlled Trials Register (issue 4, 2001), Medline (1966 to September 2001), EmBase (1980 to August 2001), Current Contents (1993 to week 38, 2001), Biological Abstracts (1980 to June 2001), Psyclit (1967 to August 2001) and Cinahl (1982 to July 2001). We also searched the specialised register of the Cochrane Menstrual Disorders and Subfertility Group (August 2001). We also searched reference lists of articles and contacted pharmaceutical companies and experts in the field.
Randomised controlled trials comparing endometrial ablation techniques in women with a complaint of heavy menstrual bleeding without uterine pathology. The outcomes included reduction of heavy menstrual bleeding, improvement in quality of life, operative outcomes, satisfaction with outcome, complications and need for further surgery.
The two reviewers independently selected trials for inclusion, assessed trials for quality and extracted data. Attempts were made to contact authors for clarification of data in some trials. Adverse events were only assessed if they were separately measured in the included trials.
In comparing hysteroscopic techniques, the vaporising electrode procedure was less difficult to perform (OR=0.25, 95%CI 0.1, 0.7) and had less fluid deficit (WMD=-258mls, 95% CI -342.1, -174.0) than TCRE. The odds of fluid overload and equipment failure were higher ((OR=5.2, 95% CI 1.5, 18.4) and (OR=6.0, 95% CI 1.7, 20.9) respectively) for those women having laser as compared to TCRE (transcervical resection of the endometriuim). In comparing traditional hysteroscopic endometrial ablation with the newer 2nd generation techniques overall, the newer techniques took less time to perform (WMD=-11mins, 95% CI -18.6, -2.6) and were more likely to be performed under local anaesthesia (OR=7.6, 95% CI 1.1, 52.7) but had a greater chance of equipment failure (OR=4.1, 95% CI 1.1, 15.0). The reduction in heavy bleeding did not differ significantly between any of the groups.
REVIEWER'S CONCLUSIONS: Endometrial ablation techniques continue to play an important role in the management of HMB. The rapid development of a number of new methods of endometrial destruction has made systematic comparisons between methods and with the "gold standard" of TCRE difficult. Most of the newer techniques are performed blind and are technically easier than hysteroscopy-based methods. Overall, the existing evidence suggests success rates and complication profile of newer techniques of ablation compares favourably with TCRE, although technical difficulties with new equipment need to be ironed out.
月经过多(HMB)是绝经前女性的一个重要健康问题,会降低生活质量并导致贫血。传统的一线治疗方法是药物治疗,但并不总是完全有效。子宫切除术常用于药物治疗失败后,虽然100%有效,但存在风险、成本高且会引发并发症。子宫内膜消融术侵入性较小、成本较低且能保留子宫。已开发出大量技术来“消融”(去除)子宫内膜。金标准技术(激光、经宫颈子宫内膜切除术和滚球术)需要用宫腔镜观察子宫,虽然安全,但需要技术熟练的外科医生。最近开发了一些更新的技术,其中大多数可以盲目操作且耗时较少。这些技术中的许多仍在开发、完善和研究中。
比较用于破坏子宫内膜以减少绝经前女性月经过多的方法的疗效、安全性和可接受性。
我们检索了Cochrane对照试验注册库(2001年第4期)、Medline(1966年至2001年9月)、EmBase(1980年至2001年8月)、《现刊目次》(1993年至2001年第38周)、《生物学文摘》(1980年至2001年6月)、Psyclit(1967年至2001年8月)和Cinahl(1982年至2001年7月)。我们还检索了Cochrane月经紊乱与生育力低下小组的专业注册库(2001年8月)。我们还检索了文章的参考文献列表,并联系了制药公司和该领域的专家。
比较无子宫病变但主诉月经过多的女性的子宫内膜消融技术的随机对照试验。结局包括月经过多的减少、生活质量的改善、手术结局、对结局的满意度、并发症以及进一步手术的需求。
两位综述作者独立选择纳入试验,评估试验质量并提取数据。在某些试验中,尝试联系作者以澄清数据。仅当纳入试验中分别测量了不良事件时才对其进行评估。
在比较宫腔镜技术时,与经宫颈子宫内膜切除术(TCRE)相比,汽化电极手术操作难度较小(OR = 0.25,95%CI 0.1,0.7)且液体缺失较少(WMD = -258毫升,95%CI -342.1,-174.0)。与TCRE相比,接受激光治疗的女性发生液体过载和设备故障的几率更高(分别为OR = 5.2,95%CI 1.5,18.4和OR = 6.0,95%CI 1.7,20.9)。总体而言,在比较传统宫腔镜子宫内膜消融术与更新的第二代技术时,更新的技术操作时间更短(WMD = -11分钟,95%CI -18.6,-2.6),更有可能在局部麻醉下进行(OR = 7.6,95%CI 1.1,52.7),但设备故障的几率更大(OR = 4.1,95%CI 1.1,15.0)。各治疗组之间月经过多的减少没有显著差异。
子宫内膜消融技术在月经过多的管理中继续发挥重要作用。多种新的子宫内膜破坏方法的快速发展使得对这些方法之间以及与TCRE“金标准”进行系统比较变得困难。大多数更新的技术是盲目操作的,并且在技术上比基于宫腔镜的方法更容易。总体而言,现有证据表明,尽管新设备的技术难题需要解决,但更新的消融技术的成功率和并发症情况与TCRE相比具有优势。